UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk
|
2020-07-16 14:16
라인
US-based Psomagen stocks shot up on 1st day of Kosdaq listing
The shares prices of Psomagen, a U.S.-based company specializing in genome ...
by Kim Chan-hyuk
|
2020-07-13 14:56
라인
Biotech firms offer bonus shares to increase liquidity
Four listed biotech companies have announced a bonus issue in the past week...
by Kim Chan-hyuk
|
2020-07-09 14:10
라인
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate
Sixty-six manufacturers of choline alfoscerate, a dementia drug, filed an a...
by Kim Chan-hyuk
|
2020-07-09 12:52
라인
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox?
The U.S. International Trade Commission (ITC) is to give a preliminary ruli...
by Kim Chan-hyuk
|
2020-07-06 11:50
라인
‘Transabdominal cerclage raises neonatal survival’
Transabdominal cerclage in women with cervical incompetence could improve t...
by Kim Chan-hyuk
|
2020-07-03 15:52
라인
Minimally invasive TAVI procedure allows fast discharge for heart patients
Seoul St. Mary’s Hospital’s Cardio-cerebrovascular Center said Tuesday it h...
by Kim Chan-hyuk
|
2020-07-03 13:37
라인
KPBMA to expand local drugmakers’ exchanges with Europe
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) s...
by Kim Chan hyuk
|
2020-06-30 14:09
라인
Bukwang to change clinical design for Covid-19 drug candidate
Bukwang Pharm said it would modify the clinical trial design on Levovir (cl...
by Kim Chan-hyuk
|
2020-06-30 13:18
라인
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe
Samsung Bioepis’ Aybintio is expected to heat up biosimilars competition re...
by Kim Chan hyuk
|
2020-06-29 16:08
-
1
2
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top